Dr. Jamie Platt is Vice President of Genomic Solutions providing Next Generation Sequencing Services to Geneuity and MPLN. She has over 12 years of experience with proven leadership in design and development of molecular assays for use in diagnostics and clinical trials with special emphasis on Advanced Sequencing and marked success in automating clinical diagnostic assays on custom designed systems and driving innovation through adopting cutting-edge technologies. Jamie also holds Six Sigma Green Belt Certification – including Lean & DFSS. Dr.Platt is a key opinion speaker and presents at many meetings on the Advanced Sequencing Landscape and NGS assay development. PUBLICATIONS
- R.M. Kagan, Johnson E.P., Siaw M. F., Van Baelen B., Ogden R., Platt J. L., Pesano R. L., and Lefebvre E. Comparison of Genotypic and Phenotypic HIV Type 1 Tropism Assay: Results from the Screening Samples of Cenicriviron Study 202, a Randomized Phase II Trial in Treatment-Naïve Subjects. AIDS Research and Human Retroviruses. February 2014, 30(2): 151-159. doi:10.1089/aid.2013.0123.
- R.M. Kagan, Johnson, E.P., Siaw, M., Biswas, P., Chapman, D.S., Zhaohui S., Platt J.L.., and Pesano, R.L. A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients. PLoS ONE September 2012, 7(9): e46334. Doi:10.1371/journal.pone.0046334
- C.M. Strom, Rivera S; Elzinga C, Angeloni T, Rosenthal S, Goos-Root D; Siaw M; Platt J.L, Braastadt C, Cheng L, Ross D; Sun W. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory. PLoS ONE in press